These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23050130)

  • 1. Comparison of the Minimental State Examination Scale and the International HIV Dementia Scale in Assessing Cognitive Function in Nigerian HIV Patients on Antiretroviral Therapy.
    Oshinaike OO; Akinbami AA; Ojo OO; Ojini IF; Okubadejo UN; Danesi AM
    AIDS Res Treat; 2012; 2012():581531. PubMed ID: 23050130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.
    Skinner S; Adewale AJ; DeBlock L; Gill MJ; Power C
    HIV Med; 2009 Apr; 10(4):246-52. PubMed ID: 19187172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is International HIV Dementia Scale good enough to diagnose HIV-associated neurocognitive disorders?
    Himanshu D; Tandon R; Kumar S; Sawlani KK; Verma SK; Misra R; Atam V
    J Family Med Prim Care; 2022 Sep; 11(9):5060-5064. PubMed ID: 36505608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for neurocognitive impairment in HIV-infected patients and comparison of different screening tools.
    de Souza EM; Buoniconti CS; Valim FC; Moura AS
    Dement Neuropsychol; 2016; 10(1):42-46. PubMed ID: 29213430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment and neurocognitive profiles among people living with HIV and HIV-negative individuals older over 50 years: a comparison of IHDS, MMSE and MoCA.
    Chen P; Xin X; Xiao S; Liu H; Liu X; He N; Ding Y
    J Neurovirol; 2024 May; ():. PubMed ID: 38709469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
    Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
    BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
    Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
    J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological manifestation with special reference to HIV-associated neurocognitive disorder (HAND) among people on anti-retroviral treatment in India.
    Shaik RA; Holyachi S; Ahmad MS; Ahmad RK; Yusuf M; Khan M; Almutairi AB; Alghuyaythat WKZ
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6999-7004. PubMed ID: 34859862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two screening tests for HIV-Associated Neurocognitive Disorder suspected Japanese patients with respect to cART usage.
    Kami-Onaga K; Tateyama M; Kinjo T; Parrott G; Tominaga D; Takahashi-Nakazato A; Nakamura H; Tasato D; Miyagi K; Maeda S; Arae H; Uehara H; Miyagi K; Haranaga S; Fujita J
    PLoS One; 2018; 13(6):e0199106. PubMed ID: 29902251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.
    Molinaro M; Sacktor N; Nakigozi G; Anok A; Batte J; Kisakye A; Myanja R; Nakasujja N; Robertson KR; Gray RH; Wawer MJ; Saylor D
    J Acquir Immune Defic Syndr; 2020 Mar; 83(3):278-283. PubMed ID: 32032278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital.
    Mugendi AG; Kubo MN; Nyamu DG; Mwaniki LM; Wahome SK; Haberer JE
    Neurol Res Int; 2019; 2019():5173289. PubMed ID: 31781391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND.
    Chalermchai T; Valcour V; Sithinamsuwan P; Pinyakorn S; Clifford D; Paul RH; Tipsuk S; Fletcher JL; Degruttola V; Ratto-Kim S; Hutchings N; Shikuma C; Ananworanich J;
    J Neurovirol; 2013 Apr; 19(2):137-43. PubMed ID: 23483520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurocognitive impairment and characteristics of neurocognitive performance among people with HIV on antiretroviral treatment].
    Xia JJ; Wang SL; Hu YF; Shen WW; Lin HJ; Shi RZ; Ma ZH; Li ZH; Li SZ; Ding YY; Chen XX; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1651-1657. PubMed ID: 36456499
    [No Abstract]   [Full Text] [Related]  

  • 14. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
    Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
    PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, characteristics and correlates of a positive-dementia screen in patients on antiretroviral therapy in Bamenda, Cameroon: a cross-sectional study.
    Atashili J; Gaynes BN; Pence BW; Tayong G; Kats D; O'donnell JK; Ndumbe PM; Njamnshi AK
    BMC Neurol; 2013 Jul; 13():86. PubMed ID: 23855622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon.
    Njamnshi AK; Djientcheu Vde P; Fonsah JY; Yepnjio FN; Njamnshi DM; Muna WE
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):393-7. PubMed ID: 19186351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for HIV-Associated Neurocognitive Disorder (HAND) in Adults Aged 50 and Over Attending a Government HIV Clinic in Kilimanjaro, Tanzania. Comparison of the International HIV Dementia Scale (IHDS) and IDEA Six Item Dementia Screen.
    Kellett-Wright J; Flatt A; Eaton P; Urasa S; Howlett W; Dekker M; Kisoli A; Duijinmaijer A; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska E; Akinyemi R; Lwezuala B; Gray WK; Walker RW; Dotchin CL; Makupa P; Paddick SM
    AIDS Behav; 2021 Feb; 25(2):542-553. PubMed ID: 32875460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
    Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
    AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of neurocognitive disorders and depression in a Brazilian HIV population.
    Troncoso FT; Conterno Lde O
    Rev Soc Bras Med Trop; 2015; 48(4):390-8. PubMed ID: 26312927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.
    Cross S; Önen N; Gase A; Overton ET; Ances BM
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1114-22. PubMed ID: 24114509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.